share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

SEC announcement ·  Apr 5 19:04
Summary by Moomoo AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a series of open market sales transactions of Moderna's common stock on April 3, 2024. Afeyan disposed of a total of 15,000 shares at prices ranging from $97.47 to $104.15, resulting in a total market value of $1,525,268.12. Following these transactions, Afeyan directly holds 2,086,931 shares of Moderna. Additionally, Afeyan has indirect beneficial ownership of 9,666,038 shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a series of open market sales transactions of Moderna's common stock on April 3, 2024. Afeyan disposed of a total of 15,000 shares at prices ranging from $97.47 to $104.15, resulting in a total market value of $1,525,268.12. Following these transactions, Afeyan directly holds 2,086,931 shares of Moderna. Additionally, Afeyan has indirect beneficial ownership of 9,666,038 shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more